Search results
Results From The WOW.Com Content Network
QRISK3 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial ...
Cardiovascular risk screening refers to the process of assessing an individual's likelihood of developing cardiovascular diseases.The main aim of screening is to identify risk factors early and adopt preventive measures to reduce morbidity and mortality.
The Framingham Risk Score is a sex-specific algorithm used to estimate the 10-year cardiovascular risk of an individual. The Framingham Risk Score was first developed based on data obtained from the Framingham Heart Study , to estimate the 10-year risk of developing coronary heart disease. [ 1 ]
It assigns scores to individuals based on risk factors; a higher score reflects higher risk. The score reflects the level of risk in the presence of some risk factors (e.g. risk of mortality or disease in the presence of symptoms or genetic profile, risk financial loss considering credit and financial history, etc.).
In 2016, an updated PROMIS website at www.HealthMeasures.net was created to provide more information about measure selection, data collection tools, score calculation, score interpretation, item response theory, and support an online forum for posting questions to the PROMIS user community. [10]
A health risk assessment (HRA) is a health questionnaire, used to provide individuals with an evaluation of their health risks and quality of life. [5] Commonly a HRA incorporates three key elements – an extended questionnaire, a risk calculation or score, and some form of feedback, i.e. face-to-face with a health advisor or an automatic online report.
HeartScore is the interactive version of SCORE - Systematic COronary Risk Evaluation [1] - a cardiovascular disease risk assessment system initiated by the European Society of Cardiology, using data from 12 European cohort studies (N=205,178) covering a wide geographic spread of countries at different levels of cardiovascular risks.
Thus, the CHA 2 DS 2-VASc score is a refinement of CHADS 2 [8] [10] score and extends the latter by including additional common stroke risk factors, that is, age 65–74, female gender and vascular disease. [11] In the CHA 2 DS 2-VASc score, 'age 75 and above' also has extra weight, with 2 points.